What to expect when you take Tolbutamide and have Language impairment?

Do you take Tolbutamide and have Language impairment? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 22, 2018

85 reports have been studied.


Females aged 50 to 59 :

40 related reports were analyzed:

Most common symptoms:

Ascites
  • 15.0% for females aged 50 (±5) who take Tolbutamide
Dizziness
  • 15.0% for females aged 50 (±5) who take Tolbutamide
Fatigue
  • 22.5% for females aged 50 (±5) who take Tolbutamide
Nausea and vomiting
  • 22.5% for females aged 50 (±5) who take Tolbutamide

Most common co-existing conditions:

  • n/a
back to top

Males aged 50 to 59 :

45 related reports were analyzed:

Most common symptoms:

Metastases to liver
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Mucosal inflammation
  • 11.11% for males aged 50 (±5) who take Tolbutamide
Neoplasm malignant
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Pneumonia
  • 15.56% for males aged 50 (±5) who take Tolbutamide

Most common co-existing conditions:

Anaemia
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Analgesic therapy
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Antiallergic therapy
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood antidiuretic hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood corticotrophin decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood follicle stimulating hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood glucose increased
  • 11.11% for males aged 50 (±5) who take Tolbutamide
Blood luteinising hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Blood thyroid stimulating hormone decreased
  • 13.33% for males aged 50 (±5) who take Tolbutamide
High blood cholesterol
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Hypopituitarism
  • 13.33% for males aged 50 (±5) who take Tolbutamide
Renal cell carcinoma
  • 15.56% for males aged 50 (±5) who take Tolbutamide
back to top

Do you take Tolbutamide and have Language impairment:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

tolbutamide

Tolbutamide has active ingredients of tolbutamide. It is often used in diabetes. (latest outcomes from Tolbutamide 618 users)

language impairment

Language impairment (language does not develop normally in child) has been reported by people with multiple sclerosis, high blood pressure, depression, pain, rheumatoid arthritis (latest reports from 53,364 Language impairment patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.